{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:12:37Z","timestamp":1788459157605,"version":"build-2803163510"},"reference-count":44,"publisher":"American Chemical Society (ACS)","issue":"6","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["FC001092"],"award-info":[{"award-number":["FC001092"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["FC001092"],"award-info":[{"award-number":["FC001092"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["FC001092"],"award-info":[{"award-number":["FC001092"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the field of Parkinson\u2019s disease (PD) research, leucine-rich repeat kinase 2 (LRRK2) remains one of the most enigmatic kinases. LRRK2 pathogenic mutations result in increased kinase activity, making LRRK2 an attractive therapeutic target for PD. For over 10 years, the identification of a bona fide substrate and a physiological function for LRRK2 has been elusive, and only recently, Rab GTPases were identified as substrates for LRRK2 kinase activity. Additionally, LRRK2 gene expression data shows that LRRK2 is expressed at low levels in neurons and at high levels in cells of the immune system. These findings shifted research efforts from neuronal toxicity of LRRK2 mutations to the function of LRRK2 in both vesicle trafficking and the immune system, which has resulted in novel insights into the role of LRRK2 during infection and immunity. In this Perspective, we summarize the latest findings highlighting LRRK2 as a central regulator of vesicular trafficking, infection, immunity, and inflammation, speculating how LRRK2 function could influence neuronal pathology in PD.<\/jats:p>","DOI":"10.1021\/acsinfecdis.9b00051","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T18:16:17Z","timestamp":1553710577000},"page":"809-815","source":"Crossref","is-referenced-by-count":42,"title":["LRRK2 in Infection:\nFriend or Foe?"],"prefix":"10.1021","volume":"5","author":[{"given":"Susanne","family":"Herbst","sequence":"first","affiliation":[{"name":"The Francis Crick Institute , , 1 Midland Road , ,","place":["London, United Kingdom, NW1 1AT"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3199-0337","authenticated-orcid":true,"given":"Maximiliano G.","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"The Francis Crick Institute , , 1 Midland Road , ,","place":["London, United Kingdom, NW1 1AT"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"issue":"4","key":"2026090313164242900_cit1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning\nof the gene containing mutations that cause PARK8-linked Parkinson\u2019s\ndisease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"issue":"4","key":"2026090313164242900_cit2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2\ncause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"451","key":"2026090313164242900_cit3","doi-asserted-by":"publisher","first-page":"eaar5429","DOI":"10.1126\/scitranslmed.aar5429","article-title":"LRRK2 activation\nin idiopathic Parkinson\u2019s disease","volume":"10","author":"Di Maio","year":"2018","journal-title":"Sci.\nTransl. Med."},{"issue":"3","key":"2026090313164242900_cit4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/ane.12616","article-title":"An updated review of Parkinson\u2019s disease genetics\nand clinicopathological correlations","volume":"135","author":"Ferreira","year":"2017","journal-title":"Acta Neurol\nScand"},{"issue":"6384","key":"2026090313164242900_cit5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1126\/science.aar5683","article-title":"LRRK2 kinase in Parkinson\u2019s disease","volume":"360","author":"Alessi","year":"2018","journal-title":"Science"},{"key":"2026090313164242900_cit6","doi-asserted-by":"publisher","first-page":"e12813","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson\u2019s\ndisease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"eLife"},{"issue":"27","key":"2026090313164242900_cit7","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1056\/NEJMoa0903753","article-title":"Genomewide association\nstudy of leprosy","volume":"361","author":"Zhang","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"2026090313164242900_cit8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/gene.2014.72","article-title":"Association\nof the LRRK2 genetic polymorphisms with leprosy in Han Chinese from\nSouthwest China","volume":"16","author":"Wang","year":"2015","journal-title":"Genes Immun."},{"issue":"6","key":"2026090313164242900_cit9","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1042\/BST20180470","article-title":"LRRK2 and Rab GTPases","volume":"46","author":"Pfeffer","year":"2018","journal-title":"Biochem. Soc. Trans."},{"issue":"6","key":"2026090313164242900_cit10","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1042\/BST20160228","article-title":"Cellular functions of LRRK2 implicate\nvesicular trafficking pathways in Parkinson\u2019s disease","volume":"44","author":"Cookson","year":"2016","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"2026090313164242900_cit11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1042\/BST20160392","article-title":"Cellular effects mediated by pathogenic\nLRRK2: homing in on Rab-mediated processes","volume":"45","author":"Madero-Perez","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"2026090313164242900_cit12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4161\/sgtp.25604","article-title":"Functional role(s) of phagosomal\nRab GTPases","volume":"4","author":"Gutierrez","year":"2013","journal-title":"Small GTPases"},{"issue":"22","key":"2026090313164242900_cit13","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.15252\/embj.201591593","article-title":"Phosphoproteomic screening identifies\nRab GTPases as novel downstream targets of PINK1","volume":"34","author":"Lai","year":"2015","journal-title":"EMBO J."},{"issue":"13","key":"2026090313164242900_cit14","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1084\/jem.20160597","article-title":"RAB43 facilitates cross-presentation of cell-associated\nantigens by CD8alpha+ dendritic cells","volume":"213","author":"Kretzer","year":"2016","journal-title":"J. Exp.\nMed."},{"key":"2026090313164242900_cit15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fcimb.2017.00435","article-title":"Rab GTPases\nin Immunity and Inflammation","volume":"7","author":"Prashar","year":"2017","journal-title":"Front. Cell. Infect.\nMicrobiol."},{"issue":"9","key":"2026090313164242900_cit16","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","article-title":"LRRK2 is\ninvolved in the IFN-gamma response and host response to pathogens","volume":"185","author":"Gardet","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"2026090313164242900_cit17","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1084\/jem.20170014","article-title":"LRRK2 promotes the\nactivation of NLRC4 inflammasome during Salmonella Typhimurium infection","volume":"214","author":"Liu","year":"2017","journal-title":"J. Exp. Med."},{"issue":"9","key":"2026090313164242900_cit18","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/ni.3233","article-title":"Commensal bacteria direct selective cargo sorting to\npromote symbiosis","volume":"16","author":"Zhang","year":"2015","journal-title":"Nat. Immunol."},{"issue":"12","key":"2026090313164242900_cit19","doi-asserted-by":"publisher","first-page":"e98694","DOI":"10.15252\/embj.201798694","article-title":"LRRK2 is a negative regulator of\nMycobacterium tuberculosis phagosome maturation in macrophages","volume":"37","author":"Hartlova","year":"2018","journal-title":"EMBO J."},{"issue":"6","key":"2026090313164242900_cit20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039132","article-title":"The IkappaB\nkinase family phosphorylates the Parkinson\u2019s disease kinase\nLRRK2 at Ser935 and Ser910 during Toll-like receptor signaling","volume":"7","author":"Dzamko","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"2026090313164242900_cit21","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1093\/hmg\/ddu138","article-title":"Membrane\nrecruitment of endogenous LRRK2 precedes its potent regulation of\nautophagy","volume":"23","author":"Schapansky","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"22","key":"2026090313164242900_cit22","doi-asserted-by":"publisher","first-page":"E5164","DOI":"10.1073\/pnas.1718946115","article-title":"Regulation of myeloid cell phagocytosis\nby LRRK2 via WAVE2 complex stabilization is altered in Parkinson\u2019s\ndisease","volume":"115","author":"Kim","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"2026090313164242900_cit23","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.bbamcr.2013.07.020","article-title":"Inhibition of LRRK2 kinase activity stimulates macroautophagy","volume":"1833","author":"Manzoni","year":"2013","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"444","key":"2026090313164242900_cit24","doi-asserted-by":"publisher","first-page":"eaan8162","DOI":"10.1126\/scitranslmed.aan8162","article-title":"An increase in LRRK2 suppresses autophagy\nand enhances Dectin-1-induced immunity in a mouse model of colitis","volume":"10","author":"Takagawa","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"2026090313164242900_cit25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/BCJ20170803","article-title":"Interrogating Parkinson\u2019s disease LRRK2 kinase\npathway activity by assessing Rab10 phosphorylation in human neutrophils","volume":"475","author":"Fan","year":"2018","journal-title":"Biochem. J."},{"issue":"3","key":"2026090313164242900_cit26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/mds.27601","article-title":"LRRK2-mediated Rab10 phosphorylation in immune cells\nfrom Parkinson\u2019s disease patients","volume":"34","author":"Atashrazm","year":"2019","journal-title":"Mov.\nDisord."},{"key":"2026090313164242900_cit27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-319-49969-7_7","article-title":"LRRK2 and\nthe Immune System","volume":"14","author":"Dzamko","year":"2017","journal-title":"Adv. Neurobiol"},{"issue":"6","key":"2026090313164242900_cit28","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/brain\/awy077","article-title":"Mutant\nLRRK2 mediates peripheral and central immune responses leading to\nneurodegeneration in vivo","volume":"141","author":"Kozina","year":"2018","journal-title":"Brain"},{"key":"2026090313164242900_cit29","doi-asserted-by":"publisher","first-page":"15014","DOI":"10.1038\/npjparkd.2015.14","article-title":"Why is there motor deterioration in Parkinson\u2019s\ndisease during systemic infections-a hypothetical view","volume":"1","author":"Brugger","year":"2015","journal-title":"NPJ. Parkinsons Dis"},{"issue":"8","key":"2026090313164242900_cit30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","article-title":"Anti-Tumor Necrosis Factor Therapy\nand Incidence of Parkinson Disease Among Patients With Inflammatory\nBowel Disease","volume":"75","author":"Peter","year":"2018","journal-title":"JAMA Neurol"},{"issue":"423","key":"2026090313164242900_cit31","doi-asserted-by":"publisher","first-page":"eaai7795","DOI":"10.1126\/scitranslmed.aai7795","article-title":"Functional variants in the LRRK2\ngene confer shared effects on risk for Crohn\u2019s disease and\nParkinson\u2019s disease","volume":"10","author":"Hui","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"2026090313164242900_cit32","doi-asserted-by":"crossref","unstructured":"Rivas, M. A., Koskela, J., Huang, H., Stevens, C., Avila, B. E., Haritunians, T., Neale, B., Kurki, M., Ganna, A., Graham, D., Glaser, B., Peter, I., Atzmon, G., Barzilai, N., Levine, A., Schiff, E., Pontikos, N., Weisburd, B., Karczewski, K. J., Minikel, E., Petersen, B.-S., Beaugerie, L., Seksik, P., Cosnes, J., Schreiber, S., Bokemeyer, B., Bethge, J., NIDDK IBD Genetics consortium, T2D-GENES consortium, Heap, G., Ahmad, T., Plagnol, V., Segal, A. W., Targan, S., Turner, D., Saavalainen, P., Farkkila, M., Kontula, K., Pirinen, M., Palotie, A., Brant, S. R., Duerr, R. H., Silverberg, M. S., Rioux, J. D., Weersma, R. K., Franke, A., MacArthur, D. G., Jalas, C., Sokol, H., Xavier, R. J., Pulver, A., Cho, J. H., McGovern, D. P. B., and Daly, M. J. (2019) Insights into the genetic epidemiology of Crohn\u2019s and rare\ndiseases in the Ashkenazi Jewish population.  BioRxiv, https:\/\/doi.org\/10.1101\/077180.","DOI":"10.1101\/077180"},{"issue":"3","key":"2026090313164242900_cit33","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s\ndisease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"issue":"6","key":"2026090313164242900_cit34","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota\nRegulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s\nDisease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"issue":"5","key":"2026090313164242900_cit35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1042\/BST20120119","article-title":"An emerging role\nfor LRRK2 in the immune system","volume":"40","author":"Dzamko","year":"2012","journal-title":"Biochem. Soc.\nTrans."},{"issue":"11","key":"2026090313164242900_cit36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/ni.2113","article-title":"The kinase\nLRRK2 is a regulator of the transcription factor NFAT that modulates\nthe severity of inflammatory bowel disease","volume":"12","author":"Liu","year":"2011","journal-title":"Nat. Immunol."},{"key":"2026090313164242900_cit37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fimmu.2018.00225","article-title":"Dectin-1-Syk-CARD9 Signaling Pathway in TB Immunity","volume":"9","author":"Wagener","year":"2018","journal-title":"Front. Immunol."},{"key":"2026090313164242900_cit38","unstructured":"Denali.\n          , https:\/\/www.denalitherapeutics.com\/pipeline."},{"issue":"3","key":"2026090313164242900_cit39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/jpet.115.227587","article-title":"MLi-2, a Potent,\nSelective, and Centrally Active Compound for Exploring the Therapeutic\nPotential and Safety of LRRK2 Kinase Inhibition","volume":"355","author":"Fell","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"273","key":"2026090313164242900_cit40","doi-asserted-by":"publisher","first-page":"273ra15","DOI":"10.1126\/scitranslmed.aaa3634","article-title":"Effect\nof selective LRRK2 kinase inhibition on nonhuman primate lung","volume":"7","author":"Fuji","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"2026090313164242900_cit41","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/jamaneurol.2018.1885","article-title":"Frequency of Loss of Function Variants in LRRK2 in\nParkinson Disease","volume":"75","author":"Blauwendraat","year":"2018","journal-title":"JAMA Neurol"},{"issue":"Pt B","key":"2026090313164242900_cit42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.expneurol.2017.07.019","article-title":"Achieving\nneuroprotection with LRRK2 kinase inhibitors in Parkinson disease","volume":"298","author":"West","year":"2017","journal-title":"Exp. Neurol."},{"issue":"11","key":"2026090313164242900_cit43","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1042\/BCJ20180248","article-title":"The Parkinson\u2019s\ndisease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein\nphosphorylation in mouse and human","volume":"475","author":"Mir","year":"2018","journal-title":"Biochem.\nJ."},{"key":"2026090313164242900_cit44","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/brain\/awy147","article-title":"Is Parkinson\u2019s disease a lysosomal disorder?","volume":"141","author":"Klein","year":"2018","journal-title":"Brain"}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.9b00051","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/5\/6\/809\/67303437\/acsinfecdis.9b00051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/5\/6\/809\/67303437\/acsinfecdis.9b00051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:16:48Z","timestamp":1788455808000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article\/5\/6\/809\/618360\/LRRK2-in-Infection-Friend-or-Foe"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,3,27]]},"published-print":{"date-parts":[[2019,6,14]]}},"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.9b00051","relation":{},"ISSN":["2373-8227"],"issn-type":[{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]}}}